Delivery Order SPE2DB22D1002-SPE2DB25FLHM6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,161.02 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as a child delivery order under a...
- The Defense Logistics Agency awarded a $23,646.57 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram units, with a contract ceiling value of $1,242.98. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $2,424.17 under a firm fixed-price contract type. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ZORYVE 0.3% Foam 60GM, a topical dermatological medication. This firm fixed price delivery order, valued at $1,158.98, represents a non-set-aside competitive award with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency for ZORYVE 0.3% Foam in a 60-gram unit, with a ceiling value of $1,291.47. The contract is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was awarded on a competitive basis with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,092.43 to supply ZORYVE 0.3% Foam in 60-gram units. This contract represents a child delivery order under a larger indefinite delivery contract vehicle, utilizing firm fixed-price pricing with no set-aside designation. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,983.94 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ZORYVE 0.3% FOAM 60GM medical products. The $2,415.63 firm fixed-price delivery order, which does not have a set-aside designation, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a comprehensive...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHM6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,568.13 to AmerisourceBergen Drug Corp for Zoryve 0.3% Foam 60GM on September 10, 2025, with completion targeted for September 11, 2025. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. AmerisourceBergen Drug Corp is a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products and medical supplies through its DLA contracts. This specific delivery order for Zoryve topical foam supports the broader global pharmaceutical supply mission that enables the company to deliver specialty medications, brand-name and generic drugs, and specialized medical supplies to customers including the Defense Health Agency and U.S. Coast Guard. The award reflects the contractor's capability to fulfill federal medical supply requirements through open competition without set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/10/25 |